Glycated Hemoglobin Testing Market Witnessed CAGR of 8.6% By 2026

The first five-year cumulative revenue (2017-2021) is projected to be US$ 1,946.0 Mn, which is expected to increase rather moderately over the latter part of the five-year forecast period. According to report, the glycated hemoglobin testing market is projected to reach a value of over US$ 650 Mn in 2026 at a CAGR of 8.6% over the forecast period.

Global Glycated Hemoglobin Testing Market: Competitive Analysis

The research report on the Global Glycated Hemoglobin Testing Market includes profiles of some of major companies such as Abbott Laboratories, Alere, Inc., Danaher Corp., F. Hoffmann-La Roche AG, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., ARKRAY, Inc., Bayer AG, Tosoh Corporation, and Siemens AG.